BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 38362654)

  • 1. Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Danks L; Nkambule P; Juma A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742200. PubMed ID: 34513894
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
    Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
    Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy.
    Adams C; Keller M; Michlitsch JG; Aguayo-Hiraldo P; Chen K; Hossain MZ; Davis A; Park JR; Verneris MR; Gardner RA
    Transplant Cell Ther; 2024 May; 30(5):475-487. PubMed ID: 38447751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance system in Saudi Arabia.
    Alshammari TM; Alshakka M; Aljadhey H
    Saudi Pharm J; 2017 Mar; 25(3):299-305. PubMed ID: 28344483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 impact on SADC labour markets: Evidence from high-frequency data and other sources.
    Rosenberg J; Strauss I; Isaacs G
    Afr Dev Rev; 2021 Apr; 33(Suppl 1):S177-S193. PubMed ID: 34149243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.
    Narsai K; Masekela FB; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Health Serv Res; 2024 Jan; 24(1):111. PubMed ID: 38245720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid assessment of the National Regulatory Systems for medical products in the Southern African Development Community.
    Dube-Mwedzi S; Kniazkov S; Nikiema JB; Kasilo OMJ; Fortin A; Tumusiime P; Mahlangu GN; Ndomondo-Sigonda M
    J Pharm Policy Pract; 2020; 13():64. PubMed ID: 33029353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis.
    Tiemersma EW; Ali I; Alemu A; Avong YK; Duga A; Elagbaje C; Isah A; Kay A; Mmbaga BT; Mmari E; Mwamwitwa K; Nhlabatsi S; Sintayehu K; Arefayne A; Teferi M; Cobelens F; Härmark L
    BMC Health Serv Res; 2021 Oct; 21(1):1062. PubMed ID: 34625085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
    BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of pharmacovigilance guidelines in the Southern African Development Community: A document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5755. PubMed ID: 38362654
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.